These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1432743)

  • 1. Therapeutic advances in ulcerative colitis.
    Hak S; Dukes G
    J Pract Nurs; 1992 Sep; 42(3):24-32. PubMed ID: 1432743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerative colitis and its treatment.
    Jacknowitz AI
    Am J Hosp Pharm; 1980 Dec; 37(12):1635-46. PubMed ID: 6108713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():15-21. PubMed ID: 18307645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease: Part II. Medical and surgical management.
    Hastings GE; Weber RJ
    Am Fam Physician; 1993 Mar; 47(4):811-8. PubMed ID: 8438680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and surgical management of severe colitis.
    Katz JA
    Semin Gastrointest Dis; 2000 Jan; 11(1):18-32. PubMed ID: 10706226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Take your medicine": nonadherence issues in patients with ulcerative colitis.
    Turnbough L; Wilson L
    Gastroenterol Nurs; 2007; 30(3):212-7; quiz 218-9. PubMed ID: 17568260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the management of mild to severe acute ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():88-92. PubMed ID: 15352901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis: diagnosis and treatment.
    Langan RC; Gotsch PB; Krafczyk MA; Skillinge DD
    Am Fam Physician; 2007 Nov; 76(9):1323-30. PubMed ID: 18019875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on medical management of inflammatory bowel disease: ulcerative colitis.
    Hanauer SB
    Rev Gastroenterol Disord; 2001; 1(4):169-76. PubMed ID: 12120183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].
    Rogozina VA; Rumiantsev VG
    Eksp Klin Gastroenterol; 2003; (1):58-9, 183. PubMed ID: 12664788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of distal ulcerative colitis: frequently asked questions analysis.
    James SL; Irving PM; Gearry RB; Gibson PR
    Intern Med J; 2008 Feb; 38(2):114-9. PubMed ID: 18290827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
    Levine DS; Fischer SH; Christie DL; Haggitt RC; Ochs HD
    Am J Gastroenterol; 1992 Jan; 87(1):91-100. PubMed ID: 1728132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.